mRCC: promising new combinations lead to disruption in L1 and L2
Targeted therapies, particularly tyrosine kinase inhibitors (TKI) dominate the treatment of...
Posts about
Oncology (2)
Social Media Insights: ASCO 2020 Part 2
hemato-oncology, Social Media Listening, Oncology
TheAmerican Society of Oncologists (ASCO) annual meetingisa majorfixture in theglobal oncology
Social Media Insights: ASCO 2020 Part 1
hemato-oncology, Social Media Listening, Oncology
TheAmerican Society of Oncologists (ASCO) annual meetingisa majorfixture in theglobal oncology
Social Media Listening: Insights from Healthcare conferences
Market Research Industry, hemato-oncology, Social Media Listening, Oncology
Healthcare conferences provide unique opportunities to gain first-hand insights from otherwise...
DLBCL Market Overview
hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology
Following the release of our latest ebook, this is the first blog post in this series focusing on...
New AplusA eBook Covers the DLBCL Market
AplusA News, hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology
Introducing the latest eBook in AplusA's Hemato-Oncology series
DLBCL Case Study: Enhancing Patient Journey Research with Social Media Listening
hemato-oncology, DLBCL market, Social Media Listening, Syndicated Studies, Oncology
Using the example of a recent AplusA study in Diffuse Large B-Cell Lymphoma (DLBCL), we consider...
Patient Insights from AplusA’s Multiple Myeloma Tracker
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...
Multiple Myeloma Market Dynamics Revealed by AplusA Tracker
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...
Brand Performance Insights from AplusA's Multiple Myeloma Tracker
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology